Myositis can be difficult to treat. There are no standard treatment guidelines to follow, and the disease is heterogenous. Conventional treatment consists of steroids and an immunosuppressant such as Methotrexate, Azathioprine or Mycophenolate Mofetil. If patients continue to be symptomatic after an adequate trial of at least 3 months on therapeutic doses of these medications, this is considered refractory disease. Other treatment strategies that can be employed in this situation are discussed in this concise article. (Registration is Required)
Receive the Latest News from Johns Hopkins Rheumatology
Join our mailing list to receive the latest news and updates from Johns Hopkins Rheumatology.